Crossref

1. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

2. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

- Seyed Moayed Alavian

- Heidar Sharafi

3. Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis

- Mohammad Ehsan Bayatpoor

- Mohammad Hossein Khosravi

- Heidar Sharafi

- Mohammad Saeid Rezaee-Zavareh

- Bita Behnava

- Seyed Moayed Alavian

4. Prevalence of Occult HCV Infection in Hemodialysis and Kidney-Transplanted Patients: A Systematic Review

- Fardin Dolatimehr

- Mohammad Hossein Khosravi

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

5. Signature of natural resistance in NS3 protease revealed by deep sequencing of HCV strains circulating in Iran

- Lize Cuypers

- Marijn Thijssen

- Arash Shakibzadeh

- Ward Deboutte

- Jamal Sarvari

- Farzaneh Sabahi

- Mehrdad Ravanshad

- Mahmoud Reza Pourkarim

6. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy

- Seyyed Mohammad Miri

- Heidar Sharafi

- Ali Pouryasin

- Bita Behnava

- Maryam Keshvari

- Shima Salimi

- Pegah Karimi Elizee

- Seyed Moayed Alavian

7. Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

- Heidar Sharafi

- Mehri Nikbin

- Seyed Hoda Alavian

- Bita Behnava

- Seyed Moayed Alavian

8. Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Bita Behnava

- Seyed Moayed Alavian

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

9. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients

- Kazem Baesi

- Ali Akbar Velayati

- Masoumeh Farrokh Ashtiani

- Kamal Fakhredini

- Mohammad Banifazl

- Mona Sadat Larijani

- Parya Basimi

- Amitis Ramezani

10. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

- Fardin Dolatimehr

- Hamidreza Karimi-Sari

- Mohammad Saeid Rezaee-Zavareh

- Seyed Moayed Alavian

- Bita Behnava

- Mohammad Gholami-Fesharaki

- Heidar Sharafi

11. Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

- Masood Ziaee

- Morteza Hajihosseini

12. Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

- Khashayar Hesamizadeh

- Seyed Moayed Alavian

- Azar Najafi Tireh Shabankareh

- Heidar Sharafi

13. Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation

- M. S. Rezaee‐Zavareh

- S. M. Alavian

14. Research progress on the direct antiviral drugs for hepatitis C virus

- Jianjun Gao

- Chuanxia Ju

15. Methadone Maintenance Therapy (MMT) Clients Should Be More Noticed for Hepatitis C Elimination in Iran

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

16. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges

- Reza Taherkhani

- Fatemeh Farshadpour

17. Aflatoxin B1 exposure and the risk of hepatocellular carcinoma in Iranian carriers of viral hepatitis B and C

- Nasim Habibi

- Mohsen Nassiri-Toosi

- Heidar Sharafi

- Seyed Moayed Alavian

- Masoomeh Shams-Ghahfarokhi

- Mehdi Razzaghi-Abyaneh

18. Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies

- Meisam Moghimbeygi

- Seyed Moayed Alavian

19. Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C

- Hala Rady Ahmed

- Nancy G. F. M. Waly

- Rehab Mahmoud Abd El-Baky

- Ramadan Yahia

- Helal F. Hetta

- Amr M. Elsayed

- Reham Ali Ibrahem

- Philippe Gallay

20. Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection

- Najmeh Rokhtabnak

- Mohammad Reza Ataollahi

- Morvarid Asadipour

- Mohammad Ali-Hassanzadeh

- Pooria Fazeli

- Soolmaz Khansalar

- Esmaeel Ghani

- Kurosh Kalantar

21. Lurking epidemic of hepatitis C virus infection in Iran: A call to action

- Reza Taherkhani

- Fatemeh Farshadpour

22. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

- Marcarious M. Tantuoyir

- Muhammed Camara

- Marjan Sohrabi

- SeyedAhmad SeyedAlinaghi

- Zahra Ahmadinejad

23. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Heidar Sharafi

- Farzin Sadeghi

- Mohammad Gholami-Fesharaki

- Alireza Farasat

- Fatemeh Jahanpeyma

- Seyed Moayed Alavian

24. Evaluating Drug Resistant Mutations to HCV NS3 Protease Inhibitors in Iranian Naïve Patients

- Tayebeh Hashempour

- Behzad Dehghani

- Zahra Mousavi

- Maryam Yahaghi

- Zahra Hasanshahi

- Javad Moayedi

- Tahereh Akbari

- Mohammad Ali Davarpanah

25. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia

- Arezoo Khosravi

- Hamidreza Karimi‐Sari

- Mahdi Abedi‐Andani

- Bita Behnava

- Ali Namvar

- Ali Anvar

- Seyed Moayed Alavian

26. Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population

- Amitis Ramezani

- Kazem Baesi

- Mohammad Banifazl

- Minoo Mohraz

- Farzin Khorvash

- Majid Yaran

- Payam Tabarsi

- Amir hosein Dalirrooyfard

- Fatemeh Motevalli

- Anahita Bavand

- Arezoo Aghakhani

27. Assessing the Quality of Clinical Practice Guidelines in the Middle East and North Africa (MENA) Region: A Systematic Review

- Saja H Almazrou

- Layan A Alsubki

- Norah A Alsaigh

- Wadha H Aldhubaib

- Sharifah M Ghazwani

28. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients

- Zahra Hasanshahi

- Ava Hashempour

- Farzane Ghasabi

- Javad Moayedi

- Zahra Musavi

- Behzad Dehghani

- Heidar Sharafi

- Hassan Joulaei

29. Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

- Soheila Khosravi

- Heidar Sharafi

- Esmaeil Sanei Moghadam

- Fariba Heidari

- Mahmod Naibzadeh

- Seyed Moayed Alavian

30. Chronic Hemodialysis Patients; Special Group for Hepatitis C Elimination Programs in Iran

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

31. Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

- Seyyed Mohammad Miri

- Heidar Sharafi

- Shima Salimi

- Farah Bokharaei-Salim

- Bita Behnava

- Maryam Keshvari

- Pegah Karimi Elizee

- Hosein Keyvani

- Seyed Moayed Alavian

32. Update on Transmission Modes of Hepatitis C Virus Among Volunteer Iranian Blood Donors: Analysis of a Matched Case-Control Study by Penalized Conditional Logistic Regression

- Fahimeh Ranjbar Kermani

- Kamran Mousavi Hosseini

- Sedigheh Amini Kafi-abad

- Mahtab Maghsudlu

- Zohreh Sharifi

- Mohammad Ali Mansournia

- Seyed Moayed Alavian

33. SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

- Shahin Merat

- Shahin Merat

- Amir-Houshang Sharifi

- Hossein Poustchi

- Eskandar Hajiani

- Abdolsamad Gharavi

- Jalal Karimi

- Fariborz Mansour-Ghanaei

- Mohammad-Reza Fattahi

- Lida Ahmadi

- Mohammad-Hossein Somi

- Hamid Kalantari

- Mohammad-Reza Ghadir

- Farshad Sheikhesmaeili

- Nadieh Baniasadi

- Masoudreza Sohrabi

- Seyedhamid Moosavy

- Masood Ziaee

- Mohammad-Javad Zahedi

- Marjan Mokhtare

- Shahnaz Sali

- Babak Sayad

- Behrooz Afshar

- Alireza Bakhshipour

- Abazar Parsi

- Afsaneh Sharifian

- Taghi Amiriani

- Zeinab Malekzadeh

- Dorsa Merat

- Azita Ganji

- Fereidoun Rahmani-Samani

- Raika Jamali

- Masoomeh Sofian

- Mohammad Ghezlou

- Amir Ali Sohrabpour

- Ladan Goshayeshi

- Seyed-Mohammad Valizadeh-Toosi

- Layli Eslami

- Iradj Maleki

- Ahmad Hormati

- Ali-Akbar Shayesteh

- Elahe Shayesteh

- Alireza Norouzi

- Zahra Abna

- Alireza Janbakhsh

- Hafez Fakheri

- Mohammad Minakari

- Hossein Sardarian

- Adel Fallah Ghajary

- Mojtaba Fattahi-Abdizadeh

- Maryam Latifnia

- Fatemeh Roozbeh

- Shahram Agah

- Saba Fakhrieh-Asl

- Alireza Nateghi-Baygi

- Babak Fattahi

- Helia Nateghi-Baygi

- Andrew Hill

- Reza Malekzadeh

34. The Efficacy and Safety of Sofosbuvir/Daclatasvir Fixed-Dose Combination in Iranian Hemodialysis Patients with Hepatitis C Virus Infection

- Kasra Ghanaat

- Heidar Sharafi

- Seyed Moayed Alavian

35. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

- Saman Mohazzab-Torabi

- Fardin Dolatimehr

- Heidar Sharafi

- Mahdi Safi-Abadi

- Mohammad Saeid Rezaee-Zavareh

- Ehsan Bayatpour

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

36. Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation

- Ashly E. Jordan

- David C. Perlman

- Charles M. Cleland

- Katarzyna Wyka

- Bruce R. Schackman

- Denis Nash

37. Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents

- H. Karimi-Sari

- M.A. Hosseini

- N. Nikjoo

- M.S. Bagheri Baghdasht

- S.M. Alavian

38. Awareness Campaign in (bio)Medical Students in Iran: a model for increasing the knowledge regarding hepatitis B and C

- H. Karimi-Sari

- M.E. Bayatpoor

- S.M. Alavian

39. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

40. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study

- Ali Mirzazadeh

- Samira Hosseini-Hooshyar

- Armita Shahesmaeili

- Heidar Sharafi

- Mohammad Shafiei

- Jasem Zarei

- Ghazal Mousavian

- Fatemeh Tavakoli

- Nima Ghalekhani

- Mostafa Shokoohi

- Mehrdad Khezri

- Soheil Mehmandoost

- Mohammad Reza Shojaei

- Mohammad Karamouzian

- Alya Briceno

- Meghan D. Morris

- Seyed Moayed Alavian

- Ali-Akbar Haghdoost

- Hamid Sharifi

- Kimberly A. Page

41. The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3

- Shahin Merat

- Amir Houshang Sharifi

- Arghavan Haj-Sheykholeslami

- Hossein Poustchi

- Babak Fattahi

- Alireza Nateghi-Baygi

- Seyed Moayed Alavian

- Reza Malekzadeh

42. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

43. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis

- Mohammad Saeid Rezaee-Zavareh

- Khashayar Hesamizadeh

- Heidar Sharafi

- Seyed Moayed Alavian

44. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis

- Masoud Behzadifar

- Hassan Abolghasem Gorji

- Nicola Luigi Bragazzi

45. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

- Heidar Sharafi

- Seyed Moayed Alavian

46. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis

- Babak Mirminachi

- Zahra Mohammadi

- Shahin Merat

- Afarin Neishabouri

- Amir Houshang Sharifi

- Seyed Hoda Alavian

- Hosein Poustchi

- Reza Malekzadeh

47. Controversies in the Screening of Hepatitis C Virus Among First-Degree Family Members of the Affected Patients

- Parivash Davoodian

- Hamidreza Mahboobi

48. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

- Heidar Sharafi

- Bita Behnava

- Alireza Azizi-saraji

- Ali Namvar

- Ali Anvar

- Shima Salimi

- Seyed Moayed Alavian